NM_022725.4(FANCF):c.394A>G (p.Ser132Gly) AND Ovarian cancer

Germline classification:: Benign (1 submission)
Last evaluated:: Jan 1, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003154739.2

Allele description [Variation Report for NM_022725.4(FANCF):c.394A>G (p.Ser132Gly)]

NM_022725.4(FANCF):c.394A>G (p.Ser132Gly)

Gene:

FANCF:FA complementation group F [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

11p14.3

Genomic location:

Preferred name:

NM_022725.4(FANCF):c.394A>G (p.Ser132Gly)

HGVS:

NC_000011.10:g.22625417T>C
NG_007425.1:g.5425A>G
NG_122096.1:g.131T>C
NM_022725.4:c.394A>GMANE SELECT
NP_073562.1:p.Ser132Gly
NP_073562.1:p.Ser132Gly
LRG_527t1:c.394A>G
LRG_527:g.5425A>G
LRG_527p1:p.Ser132Gly
NC_000011.9:g.22646963T>C
NM_022725.3:c.394A>G

Protein change:

S132G

Molecular consequence:

NM_022725.4:c.394A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Ovarian cancer
Synonyms:: OVARIAN CANCER, SOMATIC
Identifiers:: MONDO: MONDO:0008170; MedGen: C1140680; OMIM: 167000

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003843594	Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University	criteria provided, single submitter (ACMG Guidelines, 2015)	Benign (Jan 1, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003843594

Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University

criteria provided, single submitter

(ACMG Guidelines, 2015)

Benign
(Jan 1, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University, SCV003843594.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jun 17, 2024

ClinVar

Relating variation to medicine